MA23356A1 - ANTI-VIRAL AGENTS - Google Patents

ANTI-VIRAL AGENTS

Info

Publication number
MA23356A1
MA23356A1 MA23679A MA23679A MA23356A1 MA 23356 A1 MA23356 A1 MA 23356A1 MA 23679 A MA23679 A MA 23679A MA 23679 A MA23679 A MA 23679A MA 23356 A1 MA23356 A1 MA 23356A1
Authority
MA
Morocco
Prior art keywords
viral agents
viral
agents
Prior art date
Application number
MA23679A
Other languages
French (fr)
Inventor
Odur Ayuko Washington
Original Assignee
Radopath Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Radopath Ltd filed Critical Radopath Ltd
Publication of MA23356A1 publication Critical patent/MA23356A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525Isoalloxazines, e.g. riboflavins, vitamin B2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
MA23679A 1993-10-19 1994-10-18 ANTI-VIRAL AGENTS MA23356A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939321558A GB9321558D0 (en) 1993-10-19 1993-10-19 Anti-viral agents

Publications (1)

Publication Number Publication Date
MA23356A1 true MA23356A1 (en) 1995-07-01

Family

ID=10743784

Family Applications (1)

Application Number Title Priority Date Filing Date
MA23679A MA23356A1 (en) 1993-10-19 1994-10-18 ANTI-VIRAL AGENTS

Country Status (26)

Country Link
EP (1) EP0739208A1 (en)
JP (1) JPH09505804A (en)
CN (1) CN1140992A (en)
AP (1) AP620A (en)
AU (1) AU7943794A (en)
BG (1) BG100599A (en)
BR (1) BR9407862A (en)
CA (2) CA2123825A1 (en)
CO (1) CO4520283A1 (en)
CZ (1) CZ113796A3 (en)
EE (1) EE9600057A (en)
GB (2) GB9321558D0 (en)
HR (1) HRP940688A2 (en)
HU (1) HUT76322A (en)
IL (1) IL111338A0 (en)
JO (1) JO1866B1 (en)
MA (1) MA23356A1 (en)
MD (1) MD960168A (en)
NO (1) NO961547L (en)
OA (1) OA10579A (en)
PE (1) PE5596A1 (en)
PL (1) PL314008A1 (en)
SK (1) SK50696A3 (en)
UY (1) UY23844A1 (en)
WO (1) WO1995011028A1 (en)
ZA (1) ZA948191B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07188052A (en) * 1993-12-27 1995-07-25 Sanwa Kagaku Kenkyusho Co Ltd Interferon activity-enhancing agent and antivirus activity-enhancing composition containing the enhancing agent and interferon
US5756479A (en) * 1994-12-29 1998-05-26 Research Development Foundation Flavin adenine dinucleotide analogue inhibitors of monoamine oxidase
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
US6933285B2 (en) * 2002-05-10 2005-08-23 The Ohio State University Flavin N-oxides: new anti-cancer agents and pathogen eradication agents
ITTO20020622A1 (en) 2002-07-16 2004-01-16 Dayco Europe Srl INTEGRATED PULLEY-TORSIONAL DAMPER GROUP
EP1553099A4 (en) * 2002-08-02 2006-06-28 Inst Radiation Med Amms Pla A riboflavin derivative and its manufacture and uses
EP2545788A1 (en) * 2011-07-13 2013-01-16 Martin Hulliger Dietary multi-component system
JP2018131410A (en) * 2017-02-15 2018-08-23 ヒノキ新薬株式会社 Caspase-3 inhibitor and use thereof
SG11202003675PA (en) * 2017-10-24 2020-05-28 Lunella Biotech Inc Mitoflavoscins: targeting flavin-containing enzymes eliminates cancer stem cells (cscs) by inhibiting mitochondrial respiration
KR20220034163A (en) * 2019-07-09 2022-03-17 디에스엠 아이피 어셋츠 비.브이. Decreased viral activity of elafibrano and riboflavin or DHA

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4219545A (en) * 1979-03-23 1980-08-26 Collins Calvin E Treatment of infectious keratoconjunctivitis in animals
US4264601A (en) * 1979-06-12 1981-04-28 The Board Of Regents Of The University Of Oklahoma Antihypertensive agents and their use in treatment of hypertension
US4500524A (en) * 1982-09-15 1985-02-19 Trustees Of Boston University Tranquilizing and reducing or preventing seizures
WO1991002529A2 (en) * 1989-08-14 1991-03-07 John Bennett Kizer Product and method for killing abnormal vertebrate cells
JP2727471B2 (en) * 1989-09-14 1998-03-11 三井農林株式会社 Influenza virus infection prevention agent
US5192264A (en) * 1989-10-06 1993-03-09 The Beth Israel Hospital Association Methods and apparatus for treating disease states using oxidized lipoproteins
US5217716A (en) * 1990-07-18 1993-06-08 The Beth Israel Hospital Association Method for treating viral infections using oxidized lipoproteins
FR2674753B1 (en) * 1991-04-02 1995-03-10 Jean Berque NEW THERAPEUTIC INDICATIONS, PARTICULARLY FOR THE TREATMENT OF AIDS, OF AN ALREADY EXISTING MEDICINAL PRODUCT FROM A DENIMOUS MOLECULE OF CONTRAINDICATIONS AND ADVERSE REACTIONS.
NZ244270A (en) * 1991-09-13 1995-07-26 Eisai Co Ltd Injectable composition comprising riboflavin
WO1993010784A1 (en) * 1991-11-25 1993-06-10 University Of Michigan Therapeutic composition and method for preventing reperfusion injury
JP3073309B2 (en) * 1992-03-27 2000-08-07 雪印乳業株式会社 Sialic acid-bound 5-deazaflavin compounds

Also Published As

Publication number Publication date
PE5596A1 (en) 1996-04-18
HRP940688A2 (en) 1997-04-30
BG100599A (en) 1997-02-28
HU9601006D0 (en) 1996-06-28
PL314008A1 (en) 1996-08-05
CZ113796A3 (en) 1996-11-13
NO961547L (en) 1996-06-19
AP9400695A0 (en) 1995-01-31
HUT76322A (en) 1997-08-28
IL111338A0 (en) 1994-12-29
BR9407862A (en) 1997-05-20
CO4520283A1 (en) 1997-10-15
MD960168A (en) 1998-04-30
JO1866B1 (en) 1995-12-27
UY23844A1 (en) 1995-03-28
GB2283913A (en) 1995-05-24
AP620A (en) 1997-10-14
ZA948191B (en) 1995-06-08
CA2174552A1 (en) 1995-04-27
CA2123825A1 (en) 1995-04-20
NO961547D0 (en) 1996-04-18
JPH09505804A (en) 1997-06-10
EP0739208A1 (en) 1996-10-30
OA10579A (en) 2002-06-19
AU7943794A (en) 1995-05-08
CN1140992A (en) 1997-01-22
WO1995011028A1 (en) 1995-04-27
EE9600057A (en) 1996-10-15
SK50696A3 (en) 1997-01-08
GB9321558D0 (en) 1993-12-08
GB9421099D0 (en) 1994-12-07

Similar Documents

Publication Publication Date Title
DE69411848T2 (en) Furanylinsecticides
BR9405832A (en) Imidazoazins
FI951330A0 (en) Term
DE69413933T2 (en) ANTITUSSIVA
ATA146094A (en) WINDSIGHTER
DE69410500T2 (en) Multi-turntable
DE59407673D1 (en) 2-oximino-2-phenyl-acetamide
MA23356A1 (en) ANTI-VIRAL AGENTS
NO932166L (en) Tetningsskinne
DE59309062D1 (en) Mixer-dryer
DE59410180D1 (en) 4-Cyanophenyliminoheterocyclen
ATA179094A (en) CHAINLOCK
ATA212793A (en) SPORTSHOE
ATA194593A (en) SPORTSHOE
DE69330490T2 (en) Ladungsabtastschaltung
FI1077U1 (en) intermediate piece
ATE144907T1 (en) ROLLBOARD
DE59410298D1 (en) Hefeerntetank
DE69409638T2 (en) 2-METHYLBUTOXYETHOXYETHANOL
BR9301133A (en) Hot-ching
BR7301596U (en) Novaloteca
FIU930266U0 (en) Staedpaket
FIU930113U0 (en) Fjaerrstyrningsanordning
UA459S (en) OCCLUDOR
BR9301265A (en) Aplicatex